Filing Details

Accession Number:
0001596783-19-000017
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-20 15:48:52
Reporting Period:
2019-02-15
Accepted Time:
2019-02-20 15:48:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1596783 Catalent Inc. CTLT Pharmaceutical Preparations (2834) 208737688
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612228 William Downie C/O Catalent, Inc.
14 Schoolhouse Road
Somerset NJ 08873
Svp, Global Sales & Marketing No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-15 5,061 $20.50 44,581 No 4 M Direct
Common Stock Disposition 2019-02-15 3,688 $42.00 40,893 No 4 F Direct
Common Stock Acquisiton 2019-02-15 4,338 $24.44 45,231 No 4 M Direct
Common Stock Disposition 2019-02-15 3,377 $42.00 41,854 No 4 F Direct
Common Stock Acquisiton 2019-02-15 3,058 $31.96 44,912 No 4 M Direct
Common Stock Disposition 2019-02-15 2,671 $42.00 42,241 No 4 F Direct
Common Stock Disposition 2019-02-15 7,315 $42.00 34,926 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to purchase Common Stock Disposition 2019-02-15 5,061 $0.00 5,061 $20.50
Common Stock Options to purchase Common Stock Disposition 2019-02-15 3,058 $0.00 3,058 $31.96
Common Stock Options to purchase Common Stock Disposition 2019-02-15 4,338 $0.00 4,338 $24.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-07-30 2024-07-30 No 4 M Direct
3,059 2016-08-27 2025-08-27 No 4 M Direct
8,677 2017-07-26 2026-07-26 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.
  2. Includes restricted stock units.
  3. Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options pursuant to the Rule 10b5-1 trading plan noted in footnote 1.
  4. On July 30, 2014, the reporting person was granted options to purchase 20,244 shares of common stock of the Issuer, which vest and become exercisable in four equal annual installments beginning on July 30, 2015. (S1221)
  5. On August 27, 2015, the reporting person was granted options to purchase 12,233 shares of common stock of the Issuer, which vest and become exercisable in four equal annual installments beginning on August 27, 2016. (S10)
  6. On July 26, 2016, the reporting person was granted options to purchase 17,353 shares of common stock of the Issuer, which vest and become exercisable in four equal annual installments beginning on July 26, 2017. (S68)